Alternatively, transgenic mice expressing reduced levels of VEGF because of a mutant VEGF promoter show neurodegeneration similar to amyotrophic lateral sclerosis (ALS); this neurodegeneration is prevented by VEGF treatment [34]. This evidence concerns the gene VEGFA and amyotrophic lateral sclerosis.